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Diethylamine has been trapped in its less stable gauche
conformation in a solvate of the title diol; the staggered
conformation, which is ca. 4 kJ mol21 more stable, is found in
another solvate of the same host.
Solvation is an entropically disfavoured process during crystalliza-
tion, being observed in only around 15% of non-ionic organic
compounds in the Cambridge Structural Database.1 More rare is
when the crystal lattice of a solute molecule (host) traps a
conformationally flexible solvent molecule (guest) in one of its
higher energy conformations.2 In none of these cases, however, has
a solvate with the solvent in a more stable conformation in the same
host ever been reported. We report here the unprecedented
observation of both gauche and staggered rotamers of diethyla-
mine, 1a and 1b, in two distinct 1:1 solvates, 2a and 2b, of the host
compound 1,5-dichloro-cis-9,10-diethynyl-9,10-dihydroanthra-
cene-9,10-diol, 3. These solvates were isolated only after an
analysis of the crystal structure of unsolvated 3, which is also
reported in this communication.
Isolation of single crystals of 2a, 2b and 3 was achieved only
with careful experimentation. Hydroxy ethynylation of 1,5-di-
chloroanthraquinone (TMSC·CLi, KOH) gave predominantly the
trans-isomer, 4, with the amount of cis-isomer, 3, being so small
that it could never be separated satisfactorily with chromatography.
When the crude product was crystallized from 1:1 acetone–
benzene, two different crystal morphologies were obtained, prisms
and needles, corresponding to the cis- and trans-isomers, 3 and 4,
respectively.†
In the cis-diol 3 (Fig. 1), one of the hydroxyl groups forms an
intramolecular O–H…Cl–C hydrogen bridge (D 3.04 Å, d 2.32 Å,
q 129°), while the other donates to an intermolecular O–H…p
interaction (3.44 Å, 2.78 Å, 144°; to triple bond midpoint), with
some synthon features seen previously.3 There is an intermolecular
C–H…O–H (3.08 Å, 2.13 Å, 145°), and also an intermolecular C–
H…Cl–C bridge (3.67 Å, 2.72 Å, 146°). However, there is no
evidence of an O–H…O–H hydrogen bond.
We had noted previously, that an awkward hydrogen bond
pattern in trans-diol 4 results from the sterically constrained
environment of hydroxyl and ethynyl groups, and that this
uncomfortable pattern can relax via solvation.4 Noting further that
the packing in cis-diol 3 is reminiscent of that in 4, we crystallized
the crude mixture of isomers from Et2NH, since organic bases were
found to promote solvation very effectively.3 Crystals with
different morphologies, cuboid and plate-like, were again obtained
and two different crystals from this batch with clearly different unit
cells were found to correspond to the 1:1 solvates 2a and 2b.‡
Fig. 2 shows the conformations (1a and 1b) of Et2NH in solvates
2a and 2b. The dihedral angle between the two best planes in the
gauche and staggered conformers is 70 and 171°, respectively. In
all seven Et2NH solvates in the Cambridge Structural Database
(version 5.25, November 2003), the molecule adopts the more
stable staggered conformation.5 The energy difference between the
staggered and the gauche conformations was estimated to be 3.26
kJ mol21 (DFT) and 5.06 kJ mol21 (HF). In order to obtain a
rationale as to why the two crystal forms were obtained, the packing
in these forms was examined more carefully.
The role of solvent in improving the hydrogen bond arrangement
in 3 is without doubt. In solvate 2a (Fig. 3), the (gauche) Et2NH
Fig. 1 Crystal structure of cis-diol 3. Notice the absence of O–H…O
interactions.
Fig. 2 Gauche, 1a, (left) and staggered, 1b, (right) conformations of Et2NH
in solvates 2a and 2b.
Fig. 3 Crystal structure of solvate 2a. Notice how the solvent enters the
space between hydroxyl groups in the same molecule. Notice also the
infinite cooperative arrangement of O–H…N–H…O–H…O interactions (a,
b, c respectively in the figure) that is formed thereby.
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molecule links the intramolecular hydroxyl groups of the diol and
there is an infinite cooperative array of O–H…N (2.677 Å, 1.70 Å,
172.5°), N–H…O (3.178 Å, 2.19 Å, 166.4°) and O–H…O (2.782
Å, 1.81 Å, 170.5°) interactions. In solvate 2b too, the (staggered)
Et2NH molecule performs the same function (Fig. 4). The
cooperative array is topologically the same but the metrics are
different: O–H…N (2.709 Å, 1.72 Å, 175.5°); N–H…O (3.350 Å,
2.39 Å, 156.8°); O–H…O (2.764 Å, 1.78 Å, 173.9°). While the O–
H…N and O–H…O interactions are comparable in 2a and 2b, the
N–H…O bridge is distinctly longer in 2b (interaction e is longer
than interaction b). This lengthening of the N–H…O interaction
seems to arise from steric hindrance between one of the ethyl
groups of the solvent and the aromatic ring of the diol. When the
methyl fragment in this ethyl group swings away from the ring in
the gauche conformation, steric hindrance is reduced and the N–
H…O bridge can become shorter. We suggest that the N–H…O
lengthening in 2b is balanced by the solvent being in its most stable
staggered conformation. Alternatively, one might say that the more
energetic gauche conformation is stabilized in solvate 2a by a better
N–H…O hydrogen bond. All other packing features in the two
solvates are nearly comparable and we feel that it is reasonable to
equate the energy difference between rotamers of ca. 4 kJ mol21
with a difference of around 0.3 Å in an N–H…O hydrogen
bond.6
Finally, can one refer to these solvates as pseudopolymorphs?
The term pseudopolymorph was originally suggested by McCrone7
and it has become standard in the pharmaceutical literature.8
However, it is not generally favoured in the chemical literature.9 Its
usage suggests that there are two structures, the unsolvated and
solvated forms with different crystal structures but that because the
systems being considered are different chemical entities, the
‘polymorphism’ is not real but ‘pseudo’. However, a compound and
its solvate must necessarily have different crystal structures, and
since they are not chemically identical it is argued that there is no
question of polymorphism, pseudo or otherwise.10
We note that difficulties arise when the term polymorph is
applied to crystals that contain more than one chemical compo-
nent.11 This is because there are too many structural variations in
mixed crystals ranging from a situation wherein one of the
components is an innocuous bystander in the packing to one
wherein both components are essential to the crystal packing. In the
present case, 2a and 2b may be called polymorphs according to
currently accepted definitions. But the major features in the packing
of the major component are virtually the same. Does the term
polymorph do full justice to the chemical situation encountered?
Another possibility for 2a and 2b is to call them conformational
polymorphs.12 But is this term appropriate when the major
component has the same conformation in both forms? Any
discussion of nomenclature is, in the end, subjective but if we refer
to 2a and 2b as pseudopolymorphs of 3, a way of sharpening this
definition, given that it is the minor component in these solvates
that has the conformational variations, is to refer to them as
conformational pseudopolymorphs.13
G. R. D. thanks the DST and CSIR for financial support. J. A. K.
H. thanks the EPSRC for a Senior Research Fellowship. Fellowship
support to R. B. was provided by the UGC.
Notes and references
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Fig. 4 Crystal structure of solvate 2b. Compare this with Fig. 3. The
cooperative array is formed with interactions, d, e and f.
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